SESAM Paris to Host SimGHOSTS, EU & USA SimGHOSTS Abstracts Due March 31st, Feb. 23rd Moulage Patients Webinar

simulation paris 2017

Check out these key updates from our friends at SimGHOSTS:

SimGHOSTS to SESAM Paris – Abstracts Due Soon!

During the event our leadership secured a partnership with SESAM leadership to have SimGHOSTS run a technology track at their Paris Event June 14-16! There will be a discounted registration for those attendees only interested in the SimGHOSTS technical track. Abstracts are due for the EU event March 1st. Learn more about SimGHOSTS at SESAM here!

USA Abstracts Due March 1st

Speaking of due abstracts, will you be joining us at WakeMed in Raleigh, North Carolina this August? If so then abstracts are also due from you by March 1st. You will receive $50 off your registration if you become a presenter! Submit an abstract to USA by March 1st here!



FREE Feb 23rd Webinar

SimGHOSTS Board Secretary Lizzy Wooley has put together an awesome webinar by James Colquitt, PhD, RRT-ACCS, EMT on “Protecting Your Moulage Patients from Becoming Real Patients”. This is taking place next Thursday February 23rd, 2pm – 3pm EST. The webinar is FREE to attend and the recording will be available for subscribers.

Learning objectives:

  1. List and describe specific risks involved with the use of moulage.
  2. Describe how to recognize and treat anaphylaxis, and burns resulting during the application of moulage.
  3. Outline steps to be taken to minimize liability to simulation labs and facilities hosting simulated experiences.
Then don’t forget about these other big announcements:
If you didnt know, Annual subscription to SimGHOSTS.org costs less than a “Venti Mocha Extra Shot (hold the foam)” per month and provides more INCLUDED online resources than any other organization in the industry — and there’s even a discount per member if you sign up 3 or more simulation champions from your institution at once — so sign up today!

Don’t forget that for the latest updates follow SimGHOSTS on Twitter and LinkedIn.

Sponsored Advertisement:


Leave a Reply

*